Agilent Licenses Roche's Melting Curve Analysis Technology for PCR Applications | GenomeWeb
NEW YORK (GenomeWeb News) – Roche Diagnostics said today that it has granted a non-exclusive license of its melting curve analysis technology to Agilent Technologies
 
Under the agreement, Agilent has acquired the rights to use, develop, and sell products that are based on Roche’s melting curve analysis technique, which is used in analyzing DNA in the PCR process.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.